TLSA Valuation
Tiziana Life Sciences Ltd
$
1.810
- Overview
- Forecast
- Valuation
- Earnings
TLSA Relative Valuation
TLSA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TLSA is overvalued; if below, it's undervalued.
Historical Valuation
Tiziana Life Sciences Ltd (TLSA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.24. The fair price of Tiziana Life Sciences Ltd (TLSA) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：1.78
Fair
-10.07
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Tiziana Life Sciences Ltd. (TLSA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-8.88
EV/EBIT
Tiziana Life Sciences Ltd. (TLSA) has a current EV/EBIT of -8.88. The 5-year average EV/EBIT is -2.24. The thresholds are as follows: Strongly Undervalued below -5.67, Undervalued between -5.67 and -3.95, Fairly Valued between -0.52 and -3.95, Overvalued between -0.52 and 1.20, and Strongly Overvalued above 1.20. The current Forward EV/EBIT of -8.88 falls within the Strongly Undervalued range.
0.00
PS
Tiziana Life Sciences Ltd. (TLSA) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
-4.30
P/OCF
Tiziana Life Sciences Ltd. (TLSA) has a current P/OCF of -4.30. The 5-year average P/OCF is -2.51. The thresholds are as follows: Strongly Undervalued below -4.98, Undervalued between -4.98 and -3.74, Fairly Valued between -1.28 and -3.74, Overvalued between -1.28 and -0.04, and Strongly Overvalued above -0.04. The current Forward P/OCF of -4.30 falls within the Undervalued range.
-9.02
P/FCF
Tiziana Life Sciences Ltd. (TLSA) has a current P/FCF of -9.02. The 5-year average P/FCF is -2.72. The thresholds are as follows: Strongly Undervalued below -6.15, Undervalued between -6.15 and -4.44, Fairly Valued between -1.01 and -4.44, Overvalued between -1.01 and 0.71, and Strongly Overvalued above 0.71. The current Forward P/FCF of -9.02 falls within the Strongly Undervalued range.
Tiziana Life Sciences Ltd (TLSA) has a current Price-to-Book (P/B) ratio of 51.82. Compared to its 3-year average P/B ratio of 20.89 , the current P/B ratio is approximately 148.04% higher. Relative to its 5-year average P/B ratio of 16.82, the current P/B ratio is about 208.03% higher. Tiziana Life Sciences Ltd (TLSA) has a Forward Free Cash Flow (FCF) yield of approximately -0.75%. Compared to its 3-year average FCF yield of -19.26%, the current FCF yield is approximately -96.11% lower. Relative to its 5-year average FCF yield of -20.30% , the current FCF yield is about -96.31% lower.
51.26
P/B
Median3y
20.89
Median5y
16.82
-0.76
FCF Yield
Median3y
-19.26
Median5y
-20.30
Competitors Valuation Multiple
The average P/S ratio for TLSA's competitors is 12.92, providing a benchmark for relative valuation. Tiziana Life Sciences Ltd Corp (TLSA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of TLSA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of TLSA in the past 1 year is driven by Unknown.
People Also Watch
FAQ
Is Tiziana Life Sciences Ltd (TLSA) currently overvalued or undervalued?
Tiziana Life Sciences Ltd (TLSA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.24. The fair price of Tiziana Life Sciences Ltd (TLSA) is between to according to relative valuation methord.
What is Tiziana Life Sciences Ltd (TLSA) fair value?
How does TLSA's valuation metrics compare to the industry average?
What is the current P/B ratio for Tiziana Life Sciences Ltd (TLSA) as of Aug 30 2025?
What is the current FCF Yield for Tiziana Life Sciences Ltd (TLSA) as of Aug 30 2025?
What is the current Forward P/E ratio for Tiziana Life Sciences Ltd (TLSA) as of Aug 30 2025?